| Dr Michael Brian Reynolds, MD | |
|
1500 Commonwealth Ave, Williamsburg, VA 23185-5229 | |
| (757) 585-2250 | |
| (757) 585-2061 |
| Full Name | Dr Michael Brian Reynolds |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 16 Years |
| Location | 1500 Commonwealth Ave, Williamsburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588954838 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101253729 (Virginia) | Secondary |
| 208M00000X | Hospitalist | 0101253729 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Doctors' Hospital Of Williamsburg | Williamsburg, VA | Hospital |
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Physician Services Inc | 5092608448 | 743 |
News Archive
AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.
Physicians have a new fast-acting option for controlling the potentially crippling effects of acute agitation in patients suffering with schizophrenia and bipolar mania. The U.S. Food and Drug Administration (FDA) has approved Zyprexa® IntraMuscular (olanzapine for injection), an injectable form of Lilly's top-selling medication.
In this Reuters opinion piece, finance blogger Felix Salmon responds to a New York Times (NYT) article published on Monday in which journalist Deborah Sontag examines the global response to Haiti's cholera epidemic.
As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years.
Although Alzheimer's disease affects millions of people worldwide, there is no way to identify this devastating brain disease at its earliest stages when there still may be time to delay or even prevent the downward spiral into dementia.
› Verified 7 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.
Physicians have a new fast-acting option for controlling the potentially crippling effects of acute agitation in patients suffering with schizophrenia and bipolar mania. The U.S. Food and Drug Administration (FDA) has approved Zyprexa® IntraMuscular (olanzapine for injection), an injectable form of Lilly's top-selling medication.
In this Reuters opinion piece, finance blogger Felix Salmon responds to a New York Times (NYT) article published on Monday in which journalist Deborah Sontag examines the global response to Haiti's cholera epidemic.
As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years.
Although Alzheimer's disease affects millions of people worldwide, there is no way to identify this devastating brain disease at its earliest stages when there still may be time to delay or even prevent the downward spiral into dementia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Brian Reynolds, MD 856 J Clyde Morris Blvd, Suite A, Newport News, VA 23601-1318 Ph: () - | Dr Michael Brian Reynolds, MD 1500 Commonwealth Ave, Williamsburg, VA 23185-5229 Ph: (757) 585-2250 |
News Archive
AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.
Physicians have a new fast-acting option for controlling the potentially crippling effects of acute agitation in patients suffering with schizophrenia and bipolar mania. The U.S. Food and Drug Administration (FDA) has approved Zyprexa® IntraMuscular (olanzapine for injection), an injectable form of Lilly's top-selling medication.
In this Reuters opinion piece, finance blogger Felix Salmon responds to a New York Times (NYT) article published on Monday in which journalist Deborah Sontag examines the global response to Haiti's cholera epidemic.
As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years.
Although Alzheimer's disease affects millions of people worldwide, there is no way to identify this devastating brain disease at its earliest stages when there still may be time to delay or even prevent the downward spiral into dementia.
› Verified 7 days ago
Taylor Hanson, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 100 Sentara Cir Rm 2c, Williamsburg, VA 23188 Phone: 757-984-7217 Fax: 757-984-7210 | |
Dr. Funmilola Titilayo Ogundipe, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Sentara Cir, Williamsburg, VA 23188 Phone: 757-984-7218 | |
Dr. Amy Ann Americo, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Commonwealth Ave, Williamsburg, VA 23185 Phone: 757-585-2250 Fax: 757-585-2061 | |
Susan Enayat Pour Habibi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Sentara Cir Rm 2c, Williamsburg, VA 23188 Phone: 757-984-7217 Fax: 757-984-7210 | |
Girmay Tewoldemedhn Asgedom, M.D , M.S.P.H Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Sentara Cir Rm 2c, Williamsburg, VA 23188 Phone: 757-984-7217 Fax: 757-984-7210 | |
Dr. Kathleen A Vereb, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Sentara Cir Rm 2c, Williamsburg, VA 23188 Phone: 757-984-7217 Fax: 757-984-7210 |